- Report
- September 2022
- 100 Pages
Global
From €5344EUR$5,950USD£4,557GBP
- Report
- September 2021
- 163 Pages
Global
From €5344EUR$5,950USD£4,557GBP
- Report
- December 2022
- 77 Pages
Global
From €4445EUR$4,950USD£3,791GBP
- Report
- November 2021
- 55 Pages
Europe
From €2200EUR$2,450USD£1,877GBP
- Report
- April 2019
- 73 Pages
Global
From €4445EUR$4,950USD£3,791GBP
- Report
- November 2022
- 125 Pages
Global
From €2236EUR$2,490USD£1,907GBP
- Report
- August 2021
- 77 Pages
Global
From €4445EUR$4,950USD£3,791GBP
- Report
- May 2022
- 24 Pages
Global
- Report
- July 2023
- 280 Pages
Global
From €2200EUR$2,450USD£1,877GBP
From €1796EUR$2,000USD£1,532GBP
- Report
- March 2021
- 214 Pages
Global
From €1796EUR$2,000USD£1,532GBP
- Report
- February 2022
- 199 Pages
Global
From €2357EUR$2,625USD£2,011GBP
€4715EUR$5,250USD£4,021GBP
- Report
- October 2024
- 80 Pages
Vietnam
From €3233EUR$3,600USD£2,757GBP
- Report
- July 2022
- 40 Pages
China
From €2874EUR$3,200USD£2,451GBP
- Report
- January 2023
- 343 Pages
Global
From €4490EUR$5,000USD£3,830GBP
- Report
- January 2024
- 150 Pages
Global
From €2919EUR$3,250USD£2,489GBP
€4356EUR$4,850USD£3,715GBP
- Report
- January 2024
- 150 Pages
Global
From €2919EUR$3,250USD£2,489GBP
€4356EUR$4,850USD£3,715GBP
- Report
- November 2023
- 150 Pages
Global
From €2919EUR$3,250USD£2,489GBP
€4356EUR$4,850USD£3,715GBP
- Report
- October 2023
- 150 Pages
Global
From €2919EUR$3,250USD£2,489GBP
€4356EUR$4,850USD£3,715GBP
- Report
- October 2023
- 150 Pages
Global
From €2919EUR$3,250USD£2,489GBP
€4356EUR$4,850USD£3,715GBP

The Vaccines market is a sector of the pharmaceutical industry that focuses on the development, production, and distribution of vaccines. Vaccines are used to prevent and treat infectious diseases, and are an important part of public health initiatives. Vaccines are typically developed by pharmaceutical companies, and then approved by regulatory bodies such as the US Food and Drug Administration (FDA).
The Vaccines market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, and Johnson & Johnson. These companies are involved in the development, production, and distribution of a wide range of vaccines, including those for influenza, measles, mumps, rubella, and hepatitis. Smaller companies are also involved in the Vaccines market, such as Emergent BioSolutions and Bavarian Nordic. Show Less Read more